Credit Agricole - Egypt Bank (S.A.E.) (EGX:CIEB)
18.38
+0.02 (0.11%)
At close: Aug 4, 2025
Intra-Cellular Therapies Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Interest Income on Loans | 19,024 | 17,947 | 11,952 | 6,331 | 5,206 | 5,170 | Upgrade |
Interest Income on Investments | 38.12 | 35.54 | 8.66 | 5.18 | 10.77 | 4.4 | Upgrade |
Total Interest Income | 19,062 | 17,982 | 11,961 | 6,336 | 5,217 | 5,175 | Upgrade |
Interest Paid on Deposits | 7,882 | 6,862 | 4,497 | 2,503 | 2,254 | 2,292 | Upgrade |
Net Interest Income | 11,180 | 11,121 | 7,464 | 3,833 | 2,962 | 2,883 | Upgrade |
Net Interest Income Growth (YoY) | 16.33% | 48.99% | 94.72% | 29.40% | 2.76% | -8.29% | Upgrade |
Income From Trading Activities | 473.15 | 841.07 | 417.07 | 300.74 | 293.94 | 252.14 | Upgrade |
Gain (Loss) on Sale of Assets | 28.96 | 27.6 | 8.96 | 3.01 | 48.92 | 1.12 | Upgrade |
Gain (Loss) on Sale of Investments | 106.82 | 114.18 | 154.17 | 58.93 | 26.51 | 31.7 | Upgrade |
Other Non-Interest Income | 1,579 | 1,467 | 1,454 | 836.77 | 576.71 | 497.26 | Upgrade |
Total Non-Interest Income | 2,187 | 2,450 | 2,034 | 1,199 | 946.07 | 782.22 | Upgrade |
Non-Interest Income Growth (YoY) | -3.82% | 20.44% | 69.60% | 26.78% | 20.95% | -15.92% | Upgrade |
Revenues Before Loan Losses | 13,368 | 13,571 | 9,498 | 5,033 | 3,908 | 3,665 | Upgrade |
Provision for Loan Losses | 258.96 | 327.19 | 299.14 | 195.18 | 314.84 | 364.4 | Upgrade |
13,109 | 13,244 | 9,199 | 4,837 | 3,593 | 3,300 | Upgrade | |
Revenue Growth (YoY) | 15.71% | 43.97% | 90.17% | 34.62% | 8.88% | -23.16% | Upgrade |
Salaries and Employee Benefits | 1,250 | 1,250 | 1,040 | - | 689.64 | 690.34 | Upgrade |
Selling, General & Administrative | 1,953 | 1,510 | 1,114 | 1,639 | 658.69 | 588.25 | Upgrade |
Other Non-Interest Expense | 189.41 | -182.19 | 128.06 | -109.87 | 12.55 | 76.74 | Upgrade |
Total Non-Interest Expense | 3,392 | 2,577 | 2,282 | 1,529 | 1,361 | 1,355 | Upgrade |
EBT Excluding Unusual Items | 9,717 | 10,667 | 6,917 | 3,309 | 2,233 | 1,945 | Upgrade |
Pretax Income | 9,717 | 10,667 | 6,917 | 3,309 | 2,233 | 1,945 | Upgrade |
Income Tax Expense | 2,345 | 2,637 | 1,751 | 890.78 | 623.4 | 573.86 | Upgrade |
Earnings From Continuing Operations | 7,372 | 8,030 | 5,166 | 2,418 | 1,609 | 1,371 | Upgrade |
Minority Interest in Earnings | -0 | -0 | -0 | -0 | -0 | -0 | Upgrade |
Net Income | 7,372 | 8,030 | 5,166 | 2,418 | 1,609 | 1,371 | Upgrade |
Net Income to Common | 7,445 | 8,030 | 5,166 | 2,418 | 1,609 | 1,371 | Upgrade |
Net Income Growth | 7.37% | 55.43% | 113.68% | 50.25% | 17.35% | -41.89% | Upgrade |
Basic Shares Outstanding | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | Upgrade |
Diluted Shares Outstanding | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | Upgrade |
EPS (Basic) | 5.96 | 6.42 | 4.13 | 1.93 | 1.29 | 1.10 | Upgrade |
EPS (Diluted) | 5.96 | 6.42 | 4.13 | 1.93 | 1.29 | 1.10 | Upgrade |
EPS Growth | 16.26% | 55.43% | 113.68% | 50.25% | 17.35% | -41.89% | Upgrade |
Dividend Per Share | 3.200 | 3.200 | 1.146 | - | 0.740 | - | Upgrade |
Dividend Growth | 179.33% | 179.33% | - | - | - | - | Upgrade |
Effective Tax Rate | 24.14% | 24.72% | 25.31% | 26.92% | 27.92% | 29.50% | Upgrade |
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.